K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates - Archive ouverte HAL
Article Dans Une Revue Science Année : 2015

K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates

Benoit Witkowski
  • Fonction : Auteur
  • PersonId : 751218
  • IdHAL : bwitkowski
Nimol Khim
  • Fonction : Auteur
  • PersonId : 764211
  • IdRef : 184142334
Lei Zhang
  • Fonction : Auteur
Stephen Lam
  • Fonction : Auteur
Didier Menard

Résumé

The emergence of artemisinin resistance in Southeast Asia imperils efforts to reduce the global malaria burden. We genetically modified the Plasmodium falciparum K13 locus using zinc-finger nucleases and measured ring-stage survival rates after drug exposure in vitro; these rates correlate with parasite clearance half-lives in artemisinin-treated patients. With isolates from Cambodia, where resistance first emerged, survival rates decreased from 13 to 49% to 0.3 to 2.4% after the removal of K13 mutations. Conversely, survival rates in wild-type parasites increased from <= 0.6% to 2 to 29% after the insertion of K13 mutations. These mutations conferred elevated resistance to recent Cambodian isolates compared with that of reference lines, suggesting a contemporary contribution of additional genetic factors. Our data provide a conclusive rationale for worldwide K13-propeller sequencing to identify and eliminate artemisinin-resistant parasites.

Dates et versions

hal-01925134 , version 1 (16-11-2018)

Identifiants

Citer

Judith Straimer, Nina F. Gnadig, Benoit Witkowski, Chanaki Amaratunga, Valentine Duru, et al.. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science, 2015, 347 (6220), pp.428-431. ⟨10.1126/science.1260867⟩. ⟨hal-01925134⟩
99 Consultations
0 Téléchargements

Altmetric

Partager

More